Results 101 to 110 of about 8,980 (210)

HIPEC treatment of peritoneal carcinomatosis in colorectal and gastric cancer [PDF]

, 2015
This thesis focuses on the treatment of peritoneal metastases of gastric and colorectal cancer, specifically using cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC).
Braam, H.J.W.
core   +16 more sources

Zdravljenje bolnikov s karcinozo peritoneja s HIPEC: vloga anesteziologa [PDF]

, 2010
The diagnosis of peritoneal carcinomatosis is often associated with poor prognosis and a median survival of a few months, depending on the primary tumor.
Novak, Barbka
core   +1 more source

Small bowel obstruction and ovarian cancer: insights from a propensity-score matched study in patients with and without hyperthermic intraperitoneal chemotherapy after cytoreductive surgery

World Journal of Surgical Oncology
Background Small bowel obstruction (SBO) affects ~ 30% of ovarian cancer (OC) patients, leading to readmission, debilitating symptoms, and death within one year. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) effectively
Luis Felipe Falla-Zuniga, Armando Sardi, Mary Caitlin King, Felipe Lopez-Ramirez, Vladislav Kovalik, Sergei Iugai, Teresa Diaz-Montes, Vadim Gushchin   +7 more
doaj   +1 more source

Evaluation of the feasibility, safety, and preliminary effectiveness of hyperthermic intraperitoneal chemotherapy following radical surgery for locally advanced gastric cancer

Frontiers in Oncology
ObjectiveTo explore the feasibility, safety, and potential association between hyperthermic intraperitoneal chemotherapy (HIPEC) and peritoneal recurrence in patients with locally advanced gastric cancer following D2 radical surgery.Materials and ...
Tianze Zhang, Hang Yu, Lang Wang, Shijun Zhao, Cheng Zhao, Jie Chai, Dehai Wang   +6 more
doaj   +1 more source

The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer

Objectives: Hyperthermic intraperitoneal chemotherapy (HIPEC) is increasingly recognized as an effective addition to cytoreductive surgery in advanced ovarian cancer, particularly in patients who respond to platinum-based chemotherapy.
Chiantera, Vito, Raspagliesi, Francesco, Petrillo, Marco, De Iaco, Pierandrea, Fagotti, Anna, Vizza, Enrico, Vizzielli, Giuseppe, Bogani, Giorgio, Scollo, Paolo, Di Donato, Violante, Giannini, Andrea   +10 more
core   +1 more source

Efficacy of hyperthermic intraperitoneal chemotherapy in colorectal cancer: A phase I and III open label randomized controlled registry-based clinical trial protocol.

PLoS ONE
Standard treatment for patient with peritoneal metastases from colorectal cancer is cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). In recent years, the efficacy of oxaliplatin-based HIPEC has been challenged.
Lana Ghanipour, Gabriella Jansson Palmer, Per J Nilsson, Caroline Nordenvall, Jan-Erik Frödin, Elinor Bexe Lindskog, Dan Asplund, Torbjörn Swartling, Wilhelm Graf, Helgi Birgisson, Ingvar Syk, Victor Verwaal, Jenny Brändstedt, Peter H Cashin   +13 more
doaj   +1 more source

HIPEC and immunotherapy for ovarian cancer [PDF]

Ovarian cancer poses a significant global health burden, with mortality rates exceeding those of other gynecologic cancers. Despite initial sensitivity to chemotherapy and treatment with cytoreductive surgery, most patients experience recurrent disease ...
Aronson, S.L.
core   +3 more sources

Construction of sensitive quality index system of perioperative nursing during hyperthermic intraperitoneal chemotherapy

Huli yanjiu
ObjectiveTo construct a sensitive quality indicators system for hyperthermic intraperitoneal chemotherapy（HIPEC），and provide a scientific tool for improving nursing quality.MethodsBased on the theoretical basis of "structure⁃process⁃outcome" quality ...
XIAO Xueying, HUANG Yulin, LI Yanmei, WANG Haoyun   +3 more
doaj  

Системное влияние цисплатина при проведении процедуры HIPEC при канцероматозе брюшины

, 2017
Перитонеальный канцероматоз (ПК) по различным данным, развивается в 30–40 % случаев при опухолях ЖКТ и 65–70 % – при опухолях яичников. HIPEC – это метод лечения канцероматоза брюшины и предотвращения диссеминации опухолевых клеток в брюшине, который ...
Большой, Д. В., Пыхтеева, Е. Д., Максимовский, В. Е.   +2 more
core  

Factors influencing hematological toxicity and adverse effects of perioperative hyperthermic intraperitoneal vs intraperitoneal chemotherapy in gastrointestinal cancer

Open Medicine
Intraperitoneal (IP) chemotherapy (IPC), including hyperthermic intraperitoneal chemotherapy (HIPEC), has emerged as a promising approach to control peritoneal metastases in gastrointestinal (GI) cancers. However, the safety profile and toxicity spectrum
Zhang Xue, Zheng Zhewen, Gao Hui, Yang Ziqi, Bai Jian   +4 more
doaj   +1 more source